Literature DB >> 16382316

Clinical and molecular findings in a family with the carbonic anhydrase II deficiency syndrome.

Danny Lotan1, Arik Eisenkraft, Jeffrey M Jacobsson, Omer Bar-Yosef, Robert Kleta, Nurit Gal, Lisa Raviv-Zilka, Hagar Gore, Yair Anikster.   

Abstract

Carbonic anhydrase II (CA2) deficiency syndrome is an autosomal recessive disorder leading to osteopetrosis, renal tubular acidosis, and cerebral calcifications. Affected members of an Arab family with the CA2 deficiency syndrome carried the "Egyptian mutation" in CA2, i.e., c.191 del A, H64fsX90. One affected member, homozygote for the mutation, developed primary pulmonary hypertension. Primary pulmonary hypertension was never described before in patients with this unique syndrome. The likelihood of both occurring randomly in a single individual is very low. We therefore speculate that there might be a possibility of an etiologic link between these entities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16382316     DOI: 10.1007/s00467-005-2125-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

Review 1.  Primary pulmonary hypertension: update on pathogenesis and novel therapies.

Authors:  A C Arroliga; R A Dweik; F J Kaneko; S C Erzurum
Journal:  Cleve Clin J Med       Date:  2000-03       Impact factor: 2.321

2.  Seven novel mutations in carbonic anhydrase II deficiency syndrome identified by SSCP and direct sequencing analysis.

Authors:  P Y Hu; E J Lim; J Ciccolella; P Strisciuglio; W S Sly
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

3.  Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome.

Authors:  C McMahon; A Will; P Hu; G N Shah; W S Sly; O P Smith
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

4.  Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors:  K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

Review 5.  RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.

Authors:  Michael Schoppet; Klaus T Preissner; Lorenz C Hofbauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

Review 6.  Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.

Authors:  Patricia Collin-Osdoby
Journal:  Circ Res       Date:  2004-11-26       Impact factor: 17.367

7.  Long-term follow up of carbonic anhydrase II deficiency syndrome.

Authors:  Mohammad Awad; Abdullah A Al-Ashwal; Nadia Sakati; Abbas A Al-Abbad; Bassam S Bin-Abbas
Journal:  Saudi Med J       Date:  2002-01       Impact factor: 1.484

Review 8.  Primary pulmonary hypertension.

Authors:  James R Runo; James E Loyd
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

9.  Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis.

Authors:  C G Steward; I Pellier; A Mahajan; M T Ashworth; A G Stuart; A Fasth; D Lang; A Fischer; W Friedrich; A S Schulz
Journal:  Br J Haematol       Date:  2004-01       Impact factor: 6.998

10.  Malignant infantile osteopetrosis and primary pulmonary hypertension: a new combination?

Authors:  Kimberly A Kasow; Carmem Bonfim; Julie Asch; David A Margolis; Jesse Jenkins; Robert F Tamburro; Rupert Handgretinger; Edwin M Horwitz
Journal:  Pediatr Blood Cancer       Date:  2004-02       Impact factor: 3.167

View more
  2 in total

1.  Effect of infliximab against cisplatin-induced nephrotoxicity.

Authors:  Erkan Cure; Aynur Kirbas; Levent Tumkaya; Medine C Cure; Osman Z Sahin; Yildiray Kalkan; Suleyman Yuce; Durdu Altuner
Journal:  Saudi Med J       Date:  2014-09       Impact factor: 1.484

2.  Carbonic Anhydrase II Deficiency: A Rare Case of Severe Obstructive Sleep Apnea.

Authors:  Emanuela di Palmo; Marcella Gallucci; Elena Tronconi; Rosalba Bergamaschi; Salvatore Cazzato; Claudio La Scola; Giampaolo Ricci; Andrea Pession
Journal:  Front Pediatr       Date:  2018-07-31       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.